GlassScriptPhysician profile
Steven P Petrovas
NPI 1568775443
$1,926.76
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $792 · 2020: $254 · 2021: $337 · 2022: $168 · 2023: $55.77 · 2024: $320.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $356 · Education: $19.81.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $355.63 |
| Education | $19.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $511.81 | 2019-2024 | Wavewriter Alpha Prime 16 |
| Nevro Corp. | $480.67 | 2019-2020 | |
| Abbott Laboratories | $154.41 | 2019 | |
| Medtronic, INC. | $139.61 | 2021 | |
| Nalu Medical, INC. | $135.40 | 2024 | Nalu Neurostimulation System |
| Pfizer INC. | $127.98 | 2019 | |
| Redhill Biopharma INC. | $96.01 | 2021 | |
| Merck Sharp & Dohme LLC | $70.41 | 2023-2024 | Bridion |
| Mdd US Operations, LLC | $62.64 | 2019-2020 | |
| Metrex Research, LLC | $55.03 | 2021 | |
| Medtronic USA, INC. | $17.40 | 2020 | |
| Stimwave Technologies Incorporated | $15.49 | 2021 | |
| Si-Bone, INC. | $14.92 | 2020 | |
| Eisai INC. | $12.41 | 2020 | |
| Acelrx Pharmaceuticals, INC. | $12.11 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Virtus Pharmaceuticals LLC | $10.44 | 2020 | |
| Relievant Medsystems, INC. | $10.02 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Petrovas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.